SavedAdd your journal

Journals / The European Research Journal / 2026 / Volume: 5 Issue: 4

Spinal malignant triton tumor in a patient with neurofibromatosis type 1

Sevgi Kulaklı(Department of Dermatology, Giresun University School of Medicine, Prof. Dr. İlhan Özdemir Training and Research Hospital, Giresun, Turkey)0000-0001-7886-1060
Fazıl Kulaklı(Department of Physical Medicine and Rehabilitation, Giresun University School of Medicine, Prof. Dr. İlhan Özdemir Training and Research Hospital, Giresun, Turkey)0000-0003-0275-7093
İlker Fatih Sarı(Department of Physical Medicine and Rehabilitation, Giresun University School of Medicine, Prof. Dr. İlhan Özdemir Training and Research Hospital, Giresun, Turkey)0000-0002-7998-8992
Samet Tatlı(Department of Physical Medicine and Rehabilitation, Giresun University School of Medicine, Prof. Dr. İlhan Özdemir Training and Research Hospital, Giresun, Turkey)0000-0002-4050-0873
İlker İlhanlı(Department of Physical Medicine and Rehabilitation, Giresun University School of Medicine, Prof. Dr. İlhan Özdemir Training and Research Hospital, Giresun, Turkey)0000-0002-7998-8992
Canan Çelik(Department of Physical Medicine and Rehabilitation, Giresun University School of Medicine, Prof. Dr. İlhan Özdemir Training and Research Hospital, Giresun, Turkey)0000-0001-9418-5840
Pages
—
Publication Date
2019-07-04
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗

Abstract

No abstract available.

🔖

Cite This Article

Kulaklı, S., Kulaklı, F., Sarı, İ. F., Tatlı, S., İlhanlı, İ., Çelik, C. (2019). Spinal malignant triton tumor in a patient with neurofibromatosis type 1. The European Research Journal, Volume: 5 Issue: 4. https://doi.org/10.18621/eurj.464297

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Jouhilahti EM, Peltonen S, Heape AM, Peltonen J. The pathoetiology of neurofibromatosis 1. Am J Pathol 2011;178:1932-9.
  2. Engel EE, Brassesco MS, Valera ET, Barbosa MHN,Yamashita MEAS, Scrideli CA, et al. Clinico-genetic aspects of a pediatric non-neurofibromatosis type 1 malignant triton tumor with loss of chromosome X. Pediatr Blood Cancer 2012;59:1320-3.
  3. Kamran SC, Howard SA, Shinagare AB, Krajewski KM. Malignant peripheral nerve sheath tumors: prognostic impact of rhabdomyoblastic differentiation (malignant triton tumors), neurofibromatosis 1 status and location. EJSO 2013;39:46-52.
  4. McConnell YJ, Giacomantonio CA. Malignant triton tumors--complete surgical resection and adjuvant radiotherapy associated with improved survival. J Surg Oncol 2012;106:51-6.
  5. Lee MJ, Stephenson DA. Recent developments in neurofibromatosis type 1. Curr Opin Neurol 2007;20:135-41.
  6. Stucky CC, Johnson KN, Gray RJ, Pockaj BA, Ocal IT, Rose PS, et al. Malignant peripheral nerve sheath tumors (MPNST): the Mayo Clinic experience. Ann Surg Oncol 2012;19:878-85.
  7. Grobmyer SR, Reith JD, Shahlaee A, Bush CH, Hochwald SN. Malignant peripheral nerve sheath tumor: molecular pathogenesis and current management considerations. J Surg Oncol 2008;97:340-9.
  8. Ferner RE, Gutmann DG. International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis 1. Cancer Res 2002;62:1573-7.
  9. Moretti VM, Crawford EA, Staddon AP, Lackman RD, Ogilvie CM. Early outcomes for malignant peripheral nerve sheath tumor treated with chemotherapy. Am J Clin Oncol 2011;34:417-21.
  10. Moretti VM, Crawford EA, Staddon AP, Lackman RD, Ogilvie CM. Early outcomes for malignant peripheral nerve sheath tumor treated with chemotherapy. Am J Clin Oncol 2011;34:417-21.